The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Ryuichi Morishita

Department of Clinical Gene Therapy

Graduate School of Medicine

Osaka University

2-2 Yamada-oka



Name/email consistency: high



  • Department of Clinical Gene Therapy, Graduate School of Medicine, Osaka University, 2-2 Yamada-oka, Japan. 2003 - 2012


  1. Long-term follow-up evaluation of results from clinical trial using hepatocyte growth factor gene to treat severe peripheral arterial disease. Makino, H., Aoki, M., Hashiya, N., Yamasaki, K., Azuma, J., Sawa, Y., Kaneda, Y., Ogihara, T., Morishita, R. Arterioscler. Thromb. Vasc. Biol. (2012) [Pubmed]
  2. Hepatocyte Growth Factor Inhibits Lipopolysaccharide-Induced Oxidative Stress via Epithelial Growth Factor Receptor Degradation. Shimizu, K., Taniyama, Y., Sanada, F., Azuma, J., Iwabayashi, M., Iekushi, K., Rakugi, H., Morishita, R. Arterioscler. Thromb. Vasc. Biol. (2012) [Pubmed]
  3. Development of nucleic Acid drugs for neurological disorders. Shimamura, M., Sato, N., Nakagami, H., Taniyama, Y., Morishita, R. Curr. Top. Med. Chem (2012) [Pubmed]
  4. Modification of decoy oligodeoxynucleotides to achieve the stability and therapeutic efficacy. Osako, M.K., Nakagami, H., Morishita, R. Curr. Top. Med. Chem (2012) [Pubmed]
  5. Hepatocyte growth factor reduces cardiac fibrosis by inhibiting endothelial-mesenchymal transition. Okayama, K., Azuma, J., Dosaka, N., Iekushi, K., Sanada, F., Kusunoki, H., Iwabayashi, M., Rakugi, H., Taniyama, Y., Morishita, R. Hypertension (2012) [Pubmed]
  6. Role of central nervous system periostin in cerebral ischemia. Shimamura, M., Taniyama, Y., Katsuragi, N., Koibuchi, N., Kyutoku, M., Sato, N., Allahtavakoli, M., Wakayama, K., Nakagami, H., Morishita, R. Stroke (2012) [Pubmed]
  7. Risk Factors for Cardiovascular Events in Japanese Patients Treated with Fluvastatin from the Long-Term Event Monitoring (LEM) Study. Morishit, R., Itakuraa, H., Nakaya, N., Yoshida, M., Odawara, M., Ichihara, A., Mizuno, K. Curr. Vasc. Pharmacol (2011) [Pubmed]
  8. Phase I/IIa clinical trial of therapeutic angiogenesis using hepatocyte growth factor gene transfer to treat critical limb ischemia. Morishita, R., Makino, H., Aoki, M., Hashiya, N., Yamasaki, K., Azuma, J., Taniyama, Y., Sawa, Y., Kaneda, Y., Ogihara, T. Arterioscler. Thromb. Vasc. Biol. (2011) [Pubmed]
  9. Does gene therapy become pharmacotherapy?. Morishita, R., Aoki, M., Ogihara, T. Exp. Physiol. (2005) [Pubmed]
  10. Novel therapeutic strategy to treat brain ischemia: overexpression of hepatocyte growth factor gene reduced ischemic injury without cerebral edema in rat model. Shimamura, M., Sato, N., Oshima, K., Aoki, M., Kurinami, H., Waguri, S., Uchiyama, Y., Ogihara, T., Kaneda, Y., Morishita, R. Circulation (2004) [Pubmed]
  11. Molecular therapy to inhibit NFkappaB activation by transcription factor decoy oligonucleotides. Morishita, R., Tomita, N., Kaneda, Y., Ogihara, T. Curr. Opin. Pharmacol (2004) [Pubmed]
  12. Perspective in progress of cardiovascular gene therapy. Morishita, R. J. Pharmacol. Sci. (2004) [Pubmed]
  13. Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Morishita, R., Aoki, M., Hashiya, N., Makino, H., Yamasaki, K., Azuma, J., Sawa, Y., Matsuda, H., Kaneda, Y., Ogihara, T. Hypertension (2004) [Pubmed]
  14. Transcription factor as molecular targets: is transcription factor decoy a novel drug?. Morishita, R. Curr. Drug. Targets (2003) [Pubmed]
  15. Therapeutic potential of oligonucleotide-based therapy in cardiovascular disease. Morishita, R., Kaneda, Y., Ogihara, T. BioDrugs (2003) [Pubmed]
WikiGenes - Universities